VANCOUVER, BC – Eyam Health and iiDiagnostics (iiDX), a company formed by the Infection Innovation Consortium: iiCON, have launched a collaboration to bring forward Eyam Health’s novel vaccine technology using advanced… Read More
FRANKLIN LAKES, N.J. – BD , a leading global medical technology company, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast… Read More
Montreal (QC), Toronto (ON), Vancouver (BC) — adMare BioInnovations is proud to announce the creation of Ocythera, a new biopharmaceutical company dedicated to developing innovative therapies for rare bone diseases…. Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company), a leading global medical technology company, announced a $110 million investment to expand its production of prefillable syringes, helping accelerate biologic and GLP-1 drug… Read More
Molecular residual disease (MRD) testing detects cancer recurrence months before traditional imaging Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer… Read More
